5 Results for "

DOHH-2 cells

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "DOHH-2 cells" in MCE Product Catalog:

Cat. No.: HY-137438
CAS No.: 1858206-58-2
Purity:  99.75%
Synonyms: TG-1701
Target:  

Btk

Research Areas:  

Cancer

Edralbrutinib (TG-1701) is a highly selective, orally available irreversible BTK inhibitor, with an EC50 of 6.70 nM and a Kd of 3 nM against human BTK. Edralbrutinib inhibits downstream signaling of the B cell receptor, induces dephosphorylation of Ikaros Ser442/445, promotes nuclear exclusion of Ikaros, attenuates Ikaros gene signatures, and exerts anti-tumor activity. Edralbrutinib can be used in research related to B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-172217
CAS No.: 2982511-19-1
Research Areas:  

Cancer

DNMT1-IN-5 (Compound 55) is the inhibitor for DNMT that inhibits DNMT1 and DNMT3A with IC50 of 2.42 μM and 14.4 μM. DNMT1-IN-5 exhibits antiproliferative activity in a variety of cancer cell lines (IC50s for TMD-8, DOHH2, MOLM-13, THP-1, RPIM-8226 and HCT116 are 0.19-2.37 μM), arrests the cell cycle at G2/M phase, and induces apoptosis in TMD-8 and DOHH2 cells. DNMT1-IN-5 exhibits antitumor efficacy in TMD-8 xenograft mouse models .
loading...
    loading...
Cat. No.: HY-169307
CAS No.: 2758410-51-2
Target:  

Btk

Research Areas:  

Cancer

BTK-IN-38 (Example 125) is a potent BTK inhibitor. BTK-IN-38 inhibits DOHH2 and BT474 cells proliferation with IC50s of 114 and 340 nM, respectively .
loading...
    loading...
Cat. No.: HY-153705
CAS No.: 2562351-92-0
Target:  

Btk

Research Areas:  

Cancer

BTK-IN-25 (compound 71) is a potent inhibitor of BTK, and inhibits BTK(C481S) with an IC50 value of 0.77 nM. BTK-IN-25 inhibits BTK in DOHH2 cells with an IC50 value of 1 nM .
loading...
    loading...
Cat. No.: HY-146735
CAS No.: 2771087-94-4
Target:  

MNK Apoptosis

Research Areas:  

Cancer

MNK1/2-IN-6 is a potent and selective MNK1/2 inhibitor with IC50s of 2.3 nM and 3.4 nM for MNK1 and MNK2, respectively. MNK1/2-IN-6 induces apoptosis in a concentration-dependent manner .
loading...
    loading...